|
2023-06-09 |
2023-06-08 |
V
Vente
|
Barat Stephen
Senior VP of Therapeutics
Dirigeant
|
888
-67.8%
0,80
710 USD
|
888
-67.8%
|
0,80
|
710 USD
|
|
|
2020-01-02 |
2019-12-26 |
VP
Vente planifiée
|
JOHNSON TIM B
Executive Chairman
Administrateur exécutif
|
5 718
-2.2%
0,72
4 110 USD
|
5 718
-2.2%
|
0,72
|
4 110 USD
|
|
|
2017-12-01 |
2017-12-01 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
|
945
-2.2%
2,11
1 992 USD
|
945
-2.2%
|
2,11
|
1 992 USD
|
|
|
2017-11-03 |
2017-11-01 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
|
945
-2.1%
2,26
2 136 USD
|
945
-2.1%
|
2,26
|
2 136 USD
|
|
|
2017-10-18 |
2017-10-16 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
|
946
-2.1%
2,27
2 148 USD
|
946
-2.1%
|
2,27
|
2 148 USD
|
|
|
2017-08-25 |
2017-08-25 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
720 214
-100.0%
1,75
1 260 591 USD
|
720 214
-100.0%
|
1,75
|
1 260 591 USD
|
|
|
2017-08-25 |
2017-08-24 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
382 437
-34.7%
1,91
729 919 USD
|
382 437
-34.7%
|
1,91
|
729 919 USD
|
|
|
2017-08-25 |
2017-08-23 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
47 162
-4.1%
2,02
95 475 USD
|
47 162
-4.1%
|
2,02
|
95 475 USD
|
|
|
2017-08-22 |
2017-08-22 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
12 641
-1.0%
2,01
25 412 USD
|
12 641
-1.0%
|
2,01
|
25 412 USD
|
|
|
2017-08-22 |
2017-08-21 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
12 845
-1.0%
2,02
25 976 USD
|
12 845
-1.0%
|
2,02
|
25 976 USD
|
|
|
2017-08-22 |
2017-08-18 |
V
Vente
|
Novo Holdings A/S
Actionnaire important
|
55 100
-4.3%
2,10
115 600 USD
|
55 100
-4.3%
|
2,10
|
115 600 USD
|
|
|
2017-03-29 |
2017-03-27 |
V
Vente
|
GLAXOSMITHKLINE PLC
|
300 000
-27.5%
10,15
3 045 180 USD
|
300 000
-27.5%
|
10,15
|
3 045 180 USD
|
|
|
2016-04-05 |
2016-04-04 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
183
-1.0%
2,92
535 USD
|
183
-1.0%
|
2,92
|
535 USD
|
|
|
2016-04-05 |
2016-04-04 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
538
-1.0%
2,92
1 573 USD
|
538
-1.0%
|
2,92
|
1 573 USD
|
|
|
2016-04-05 |
2016-04-04 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
175
-0.9%
2,92
512 USD
|
175
-0.9%
|
2,92
|
512 USD
|
|
|
2016-04-05 |
2016-04-04 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
87
-0.3%
2,92
254 USD
|
87
-0.3%
|
2,92
|
254 USD
|
|
|
2016-04-05 |
2016-04-01 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
1 489
-7.8%
2,89
4 301 USD
|
1 489
-7.8%
|
2,89
|
4 301 USD
|
|
|
2016-04-05 |
2016-04-01 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
4 376
-7.9%
2,89
12 641 USD
|
4 376
-7.9%
|
2,89
|
12 641 USD
|
|
|
2016-04-05 |
2016-04-01 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
1 426
-6.6%
2,89
4 119 USD
|
1 426
-6.6%
|
2,89
|
4 119 USD
|
|
|
2016-04-05 |
2016-04-01 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
709
-2.7%
2,89
2 048 USD
|
709
-2.7%
|
2,89
|
2 048 USD
|
|
|
2016-03-14 |
2016-03-14 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
109
-0.6%
2,19
238 USD
|
109
-0.6%
|
2,19
|
238 USD
|
|
|
2016-03-14 |
2016-03-14 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
109
-0.5%
2,19
238 USD
|
109
-0.5%
|
2,19
|
238 USD
|
|
|
2016-03-14 |
2016-03-14 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
125
-0.2%
2,19
273 USD
|
125
-0.2%
|
2,19
|
273 USD
|
|
|
2016-03-14 |
2016-03-14 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
113
-0.4%
2,19
247 USD
|
113
-0.4%
|
2,19
|
247 USD
|
|
|
2016-03-14 |
2016-03-14 |
VP
Vente planifiée
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
111
-0.6%
2,19
243 USD
|
111
-0.6%
|
2,19
|
243 USD
|
|
|
2016-03-14 |
2016-03-11 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
4 215
-17.9%
2,36
9 928 USD
|
4 215
-17.9%
|
2,36
|
9 928 USD
|
|
|
2016-03-14 |
2016-03-11 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
4 305
-16.6%
2,36
10 140 USD
|
4 305
-16.6%
|
2,36
|
10 140 USD
|
|
|
2016-03-14 |
2016-03-11 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
8 154
-12.7%
2,36
19 206 USD
|
8 154
-12.7%
|
2,36
|
19 206 USD
|
|
|
2016-03-14 |
2016-03-11 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
5 264
-16.9%
2,36
12 399 USD
|
5 264
-16.9%
|
2,36
|
12 399 USD
|
|
|
2016-03-14 |
2016-03-11 |
VP
Vente planifiée
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
4 520
-19.0%
2,36
10 646 USD
|
4 520
-19.0%
|
2,36
|
10 646 USD
|
|
|
2016-03-14 |
2016-03-10 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
1 211
-4.9%
2,49
3 016 USD
|
1 211
-4.9%
|
2,49
|
3 016 USD
|
|
|
2016-03-14 |
2016-03-10 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
1 237
-4.5%
2,49
3 081 USD
|
1 237
-4.5%
|
2,49
|
3 081 USD
|
|
|
2016-03-14 |
2016-03-10 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
2 342
-3.5%
2,49
5 832 USD
|
2 342
-3.5%
|
2,49
|
5 832 USD
|
|
|
2016-03-14 |
2016-03-10 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
1 512
-4.6%
2,49
3 765 USD
|
1 512
-4.6%
|
2,49
|
3 765 USD
|
|
|
2016-03-14 |
2016-03-10 |
VP
Vente planifiée
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
1 298
-5.2%
2,49
3 232 USD
|
1 298
-5.2%
|
2,49
|
3 232 USD
|
|
|
2016-03-09 |
2016-03-09 |
VP
Vente planifiée
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
3 325
-10.9%
2,69
8 933 USD
|
3 325
-10.9%
|
2,69
|
8 933 USD
|
|
|
2016-03-09 |
2016-03-09 |
VP
Vente planifiée
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
6 299
-8.7%
2,69
16 924 USD
|
6 299
-8.7%
|
2,69
|
16 924 USD
|
|
|
2016-03-09 |
2016-03-09 |
VP
Vente planifiée
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
4 067
-11.1%
2,69
10 927 USD
|
4 067
-11.1%
|
2,69
|
10 927 USD
|
|
|
2016-03-09 |
2016-03-09 |
VP
Vente planifiée
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
3 491
-12.2%
2,69
9 379 USD
|
3 491
-12.2%
|
2,69
|
9 379 USD
|
|
|
2016-03-09 |
2016-03-09 |
VP
Vente planifiée
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
3 256
-11.6%
2,69
8 748 USD
|
3 256
-11.6%
|
2,69
|
8 748 USD
|
|
|
2015-08-25 |
2015-08-24 |
A
Achat
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
1 000
+9.3%
5,34
5 341 USD
|
1 000
+9.3%
|
5,34
|
5 341 USD
|
|
|
2015-08-24 |
2015-08-24 |
A
Achat
|
Gordon Debra A
V.P. and Chief Legal Counsel
Dirigeant
|
1 000
+280.9%
5,16
5 160 USD
|
1 000
+280.9%
|
5,16
|
5 160 USD
|
|
|
2015-08-19 |
2015-08-18 |
A
Achat
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
5 800
+828.6%
5,75
33 350 USD
|
5 800
+828.6%
|
5,75
|
33 350 USD
|
|
|
2015-08-19 |
2015-08-18 |
A
Achat
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
100
+16.7%
5,83
583 USD
|
100
+16.7%
|
5,83
|
583 USD
|
|
|
2015-08-19 |
2015-08-18 |
A
Achat
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
400
+200.0%
5,84
2 336 USD
|
400
+200.0%
|
5,84
|
2 336 USD
|
|
|
2015-08-19 |
2015-08-18 |
A
Achat
|
Roche Patrick C.
SVP Research & Development
Dirigeant
|
200
+inf%
5,83
1 166 USD
|
200
+inf%
|
5,83
|
1 166 USD
|
|
|
2015-08-13 |
2015-08-12 |
A
Achat
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
300
+2.9%
7,31
2 193 USD
|
300
+2.9%
|
7,31
|
2 193 USD
|
|
|
2015-08-13 |
2015-08-12 |
A
Achat
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
300
+3.0%
7,46
2 238 USD
|
300
+3.0%
|
7,46
|
2 238 USD
|
|
|
2015-08-13 |
2015-08-12 |
A
Achat
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
2 000
+24.6%
7,62
15 240 USD
|
2 000
+24.6%
|
7,62
|
15 240 USD
|
|
|
2015-08-13 |
2015-08-12 |
A
Achat
|
JOHNSON TIM B
President & CEO
Administrateur exécutif
|
2 400
+42.0%
7,48
17 952 USD
|
2 400
+42.0%
|
7,48
|
17 952 USD
|
|
|
2015-08-12 |
2015-08-12 |
A
Achat
|
McMeans Shaun D
VP, Finance & Admin. & CFO
Dirigeant
|
650
+22.9%
7,50
4 875 USD
|
650
+22.9%
|
7,50
|
4 875 USD
|
|
|
2015-08-12 |
2015-08-11 |
A
Achat
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
14
+0.2%
7,50
105 USD
|
14
+0.2%
|
7,50
|
105 USD
|
|
|
2015-08-12 |
2015-08-11 |
A
Achat
|
Lubniewski John L
Chief Business Officer
Dirigeant
|
4 986
+139.6%
7,67
38 243 USD
|
4 986
+139.6%
|
7,67
|
38 243 USD
|
|
|
2015-05-13 |
2015-05-11 |
A
Achat
|
Fletcher Spaght Ventures II LP
Actionnaire important
|
102 445
+24.6%
14,00
1 434 230 USD
|
102 445
+24.6%
|
14,00
|
1 434 230 USD
|
|
|
2015-05-13 |
2015-05-11 |
A
Achat
|
Merck Capital Ventures LLC
Actionnaire important
|
167 343
+28.4%
14,00
2 342 802 USD
|
167 343
+28.4%
|
14,00
|
2 342 802 USD
|
|
|
2015-05-13 |
2015-05-11 |
A
Achat
|
GLAXOSMITHKLINE PLC
Actionnaire important
|
365 106
+inf%
14,00
5 111 484 USD
|
365 106
+inf%
|
14,00
|
5 111 484 USD
|
|
|
2015-05-12 |
2015-05-11 |
A
Achat
|
Novo A/S
Actionnaire important
|
365 106
+39.9%
14,00
5 111 484 USD
|
365 106
+39.9%
|
14,00
|
5 111 484 USD
|
|
